Nan Yang

Nan Yang is a Clinical Study Director at Sanofi, possessing an M.D. and two Ph.D.s in Pathology and Gynecologic Oncology. Previously, they served as Medical Director at Lees Pharmaceutical and Medical Affairs Manager at GlaxoSmithKline, where they facilitated clinical trials and collaborated with key opinion leaders. With expertise in project management, data analysis, and medical writing, Nan also held roles at BC Cancer Agency and Syreon Clinical Research, contributing significantly to cancer surveillance and clinical data review. Their postdoctoral training at The University of Hong Kong focused on enhancing treatment sensitivity in breast cancer, complemented by a strong academic background from Peking University and the University of Groningen.